DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,289,480 | -0.4% | 33,412 | -3.6% | 1.60% | +3.0% |
| Q2 2023 | $8,321,724 | -6.9% | 34,674 | -2.2% | 1.55% | -12.7% |
| Q1 2023 | $8,937,049 | -8.2% | 35,459 | -3.3% | 1.78% | -15.7% |
| Q4 2022 | $9,730,789 | +3.9% | 36,662 | +1.1% | 2.11% | -1.3% |
| Q3 2022 | $9,363,000 | +2.6% | 36,252 | +0.8% | 2.13% | +8.5% |
| Q2 2022 | $9,122,000 | -13.8% | 35,980 | -0.3% | 1.96% | +1.2% |
| Q1 2022 | $10,582,000 | -10.4% | 36,075 | +0.5% | 1.94% | -0.1% |
| Q4 2021 | $11,806,000 | +6.3% | 35,885 | -1.6% | 1.94% | -7.0% |
| Q3 2021 | $11,107,000 | +14.2% | 36,483 | +0.7% | 2.09% | +13.2% |
| Q2 2021 | $9,725,000 | +16.6% | 36,240 | -2.2% | 1.85% | +4.9% |
| Q1 2021 | $8,340,000 | +3.8% | 37,052 | +2.5% | 1.76% | -11.6% |
| Q4 2020 | $8,033,000 | +3.1% | 36,162 | -0.1% | 1.99% | -14.3% |
| Q3 2020 | $7,794,000 | +22.5% | 36,198 | +0.6% | 2.32% | +5.2% |
| Q2 2020 | $6,360,000 | +18.7% | 35,965 | -7.1% | 2.21% | -1.0% |
| Q1 2020 | $5,359,000 | -10.1% | 38,720 | -0.3% | 2.23% | +25.9% |
| Q4 2019 | $5,963,000 | +4.3% | 38,849 | -1.9% | 1.77% | -5.5% |
| Q3 2019 | $5,718,000 | -8.5% | 39,589 | -9.5% | 1.88% | -5.3% |
| Q2 2019 | $6,249,000 | +8.7% | 43,725 | +0.4% | 1.98% | +5.0% |
| Q1 2019 | $5,751,000 | +29.0% | 43,562 | +0.8% | 1.88% | +11.8% |
| Q4 2018 | $4,458,000 | -10.4% | 43,227 | -5.6% | 1.69% | +2.5% |
| Q3 2018 | $4,977,000 | – | 45,807 | – | 1.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |